CRISPR-Cas9PD-1 targeting immune checkpoint inhibitorsPD-1-targeted CRISPR-Cas9metastatic melanomaAdoptive T cell therapyThe Danish National Committee on Health Research Ethics
…we present initial data from the first-in-human trial employing CRISPR-Cas9 to knockout PD-1 in TILs from patients with metastatic melanoma…